Neoplasms: News and Research on Sarcoma, Alveolar Soft Part

MeSH tree: C04.557.450.795.775

Long-term use of immunotherapy may be safe for patients with alveolar soft part sarcoma

Long-term adverse events were rare and manageable among patients with alveolar soft part sarcoma (ASPS), which primarily affects adolescents and young adults, who received immunotherapy beyond the standard two years, according ...

Apr 20, 2026

0

4

New alveolar soft-part sarcoma chip can mimic the microenvironment during angiogenesis

Cancer, the second leading cause of death worldwide, is more likely to respond to effective treatment if identified early before metastasizing, resulting in a greater probability of surviving.

Mar 22, 2024

0

98